FRIDAY, Sept. 3, 2021 (HealthDay News) -- In 2020, adolescent coverage with recommended vaccines remained stable, with increased coverage for human papillomavirus (HPV) vaccine, according to research published in the Sept. 3 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Cassandra Pingali, M.P.H., from the CDC in Atlanta, and colleagues estimated coverage with recommended vaccines using data from the 2020 National Immunization Survey-Teen for 20,163 adolescents aged 13 to 17 years.
The researchers found that from 2019 to 2020, there was an increase in coverage with at least one dose of HPV vaccine from 71.5 to 75.1 percent; furthermore, the percentage of adolescents up to date with HPV vaccination increased from 54.2 to 58.6 percent. Coverage with at least one dose of tetanus, diphtheria, and acellular pertussis, at least one dose of meningococcal conjugate (MenACWY), and at least two doses of MenACWY for those aged 17 years remained similar to coverage in 2019 (90.1, 89.3, and 54.4 percent, respectively). For adults aged 13 to 17 years, there was an increase in coverage for at least two doses of hepatitis A vaccine, and for those aged 17 years, there was an increase in at least one dose of serogroup B meningococcal vaccine. Higher HPV vaccination coverage was seen for adolescents living below the federal poverty levels versus those living at or above the poverty level.
"Ensuring that routine vaccination is maintained and that adolescents catch up on any missed doses is essential to protecting persons and communities from vaccine-preventable diseases and outbreaks," the authors write.
Abstract/Full Text (subscription or payment may be required)